Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, TRI

Sterling IRB Announces New North American Panel


ATLANTA, Oct. 2, 2017 /PRNewswire/ -- Today the Sterling Institutional Review Board (Sterling IRB) announced its establishment of a new North American Panel to expand Sterling's program of ethical oversight for human subjects research. 

"While maintaining a steadfast focus on protecting research participants and regulatory compliance, we aim to streamline the ethical review process with end-to-end solutions," said Ted Green, President and CEO.  "The ability to directly oversee research sites in both Canada and the United States while maintaining our commitment to high standards will result in saving time and money for our clients."    

Sterling IRB has helped lead the way in safeguarding the rights and welfare of clinical research participants for more than 25 years.  As part of the company's commitment to streamline processes, Sterling IRB provides a single-point-of-contact that focuses on clients' specific needs.  Headquartered in Atlanta, Georgia, the company's clients include pharmaceutical and biotechnology companies, clinical research organizations (CROs), research institutions, hospitals, federal agencies and individual investigators.

For more information, contact:

Kathye Richards, CIP
Sterling Institutional Review Board
Vice President of Client Services
[email protected] 
www.sterlingirb.com
1-888-636-1062

SOURCE Sterling IRB


These press releases may also interest you

at 18:50
Getting specialty medications into...

at 18:30
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

at 18:23
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

at 17:55
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

at 17:00
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...



News published on and distributed by: